1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multi-center phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401)
    Meeting Abstract

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Atkins, J. N.; Milhem, M. M.; Tap, W. D.; Antonescu, C. R.; Horvath, L. E.; Schwartz, G. K.; Streicher, H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective analysis of clinical outcomes of early stage ALK-positive (ALK+) non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Dagogo-Jack, I.; Santini, F.; Eng, J.; Yeap, B. Y.; Izar, B.; Chin, E.; Litvak, A.; Jones, D. R.; Kris, M. G.; Shaw, A. T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Borealis-2: A randomized phase II study of OGX-427 (apatorsen) plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial cancer (mUC) (Hoosier Cancer Research Network GU12-160)
    Meeting Abstract

    Choueiri, T. K.; Hahn, N. M.; Werner, L.; Regan, M. M.; Rosenberg, J. E.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Avelumab plus axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma: Phase 3 study (JAVELIN Renal 101)
    Meeting Abstract

    Choueiri, T. K.; Rini, B. I.; Larkin, J. M. G.; Bjarnason, G. A.; Gravis, G.; Gurney, H.; Lee, J. L.; Keizman, D.; Haanen, J. B. A. G.; Tomita, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A biomarker-directed phase 2 trial of SY-1425, a selective retinoic acid receptor alpha agonist, in adult patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
    Meeting Abstract

    Cook, R. J.; Stein, E.; Steensma, D. P.; Sekeres, M. A.; Bixby, D. L.; Rizzieri, D.; Jurcic, J. G.; Vigil, C. E.; Redner, R.; Roboz, G. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Institutional variation in the thoroughness of pathologic assessment and pathologic complete response rates for locally advanced rectal cancers treated with neoadjuvant chemoradiation
    Meeting Abstract

    Chow, O. S.; Patil, S.; Keskin, M.; Smith, J. J.; Widmar, M.; Smith, D. D.; Avila, K.; Shia, J.; Chu, P. G.; Garcia-Aguilar, J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Comparison of somatic mutation profiles from cell free DNA (cfDNA) versus tissue in metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Cheng, M. L.; Shady, M.; Cipolla, C. K.; Funt, S.; Arcila, M. E.; Al-Ahmadie, H.; Rosenberg, J. E.; Bajorin, D. F.; Berger, M. F.; Tsui, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Updated 5-y landmark analyses of phase 2 (BREAK-2) and phase 3 (BREAK-3) studies evaluating dabrafenib monotherapy in patients with BRAF V600-mutant melanoma
    Meeting Abstract

    Chapman, P. B.; Ascierto, P. A.; Schadendorf, D.; Grob, J. J.; Ribas, A.; Kiecker, F.; Dutriaux, C.; Demidov, L. V.; Lebbe, C.; Rutkowski, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study to assess olaparib by homologous recombination deficiency status in patients with platinum-sensitive, relapsed, ovarian, fallopian tube, or primary peritoneal cancer
    Meeting Abstract

    Cadoo, K. A.; Aghajanian, C.; Fraser, C.; Milner, A.; Kolvenbag, G.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Total neoadjuvant therapy for locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Roxburgh, C. S. D.; Strombom, P.; Smith, J. J.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P.; Garcia-Aguilar, J.; Yaeger, R. D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save